A clandestine clinic, set up inside a private residence by a self-proclaimed doctor where cosmetic procedures were performed, was discovered in Capua by the financial police of the ...
Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung ...
Sanofi and Regeneron receives Japanese marketing approval for Dupixent to treat bronchial asthma in children aged 6 to 11 years: Paris Wednesday, December 24, 2025, 11:00 Hrs [IST ...
Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo Dupix ...
Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthmaApproval based on global phase 3 program ...
Nigerian women are choosing modern family planning over tradition to improve their health, finances, and break the cycle of ...
Trying to keep up with all that's happening in the battle against Alzheimer's disease isn't easy when you're a caregiver. The ...
The approval of subcutaneous amivantamab allows physicians flexibility in offering treatment for non–small cell lung cancer.
MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...
The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and ...
Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable and needle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback